Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-20-158467
Filing Date
2020-06-02
Accepted
2020-06-02 16:11:04
Documents
12
Period of Report
2020-06-02

Document Format Files

Seq Description Document Type Size
1 6-K d904392d6k.htm 6-K 11920
2 EX-99.1 d904392dex991.htm EX-99.1 43146
3 GRAPHIC g904392page004.jpg GRAPHIC 54455
4 GRAPHIC g904392page005.jpg GRAPHIC 167762
5 GRAPHIC g904392page006.jpg GRAPHIC 163589
6 GRAPHIC g904392page007.jpg GRAPHIC 181078
7 GRAPHIC g904392page008.jpg GRAPHIC 168804
8 GRAPHIC g904392page009.jpg GRAPHIC 151246
9 GRAPHIC g904392page010.jpg GRAPHIC 83163
10 GRAPHIC g904392page011.jpg GRAPHIC 152684
11 GRAPHIC g904392page012.jpg GRAPHIC 58894
12 GRAPHIC g904392page013.jpg GRAPHIC 12543
  Complete submission text file 0001193125-20-158467.txt   1694928
Mailing Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT
Business Address 3 LOCHSIDE WAY EDINBURGH X0 EH12 9DT 44-0-131-357-1111
NuCana plc (Filer) CIK: 0001709626 (see all company filings)

EIN.: 000000000 | State of Incorp.: X0 | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-38215 | Film No.: 20937064
SIC: 2834 Pharmaceutical Preparations